The Second Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, 450014, China
NCT Number: NCT02890225
The treatment of renal calculus by retrograde intrarenal surgery(RIRS) isn't able to eliminate stone completely
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Not applicable
Zhengzhou, Henan, 450014, China
To evaluate the efficacy and safety of external physical vibration lithecbole for the treatment of residual stone in different time (3 days ,7 days and 14 days) after the operation of RIRS
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
1.Age of 18-75 years;
Exclusion criteria
1.Urinary tract anomalies, stricture or obstruction;
in 3 days after RIRS.
in10 days after RIRS.
Patients in Group C undergo EPVL in630days after RIRS.
Time frame: Patients in group A and group B return hospital respectively in 1,2 and 4 weeks after RIRS,patients in group C return hospital respectively in 2 and 4 weeks after RIRS.
Primary SFR is assessed by abdominal plain film (KUB)in different follow-up periods after operation. Stone-free status are defined as either the absence of any residual stone fragments.
Time frame: Patients in group A and group B return hospital respectively in 1,2 and 4 weeks after RIRS,patients in group C return hospital respectively in 2 and 4 weeks after RIRS.
Complication is defined as any adverse event occurred
Second Affiliated Hospital of Zhengzhou University
Other
Effect Of Renal Residual Stones c Treated By External Physical Vibration Lithecbole(EPVL) In m Different Time n After Retrograde Intrarenal w Surgery(RIRS):At y Multi-center z Prospective Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05034705
Calculi, Pathological Conditions, Anatomical
Kuala Lumpur, Malaysia
View Trial DetailsNCT01525355
Calculi, Constriction, Pathologic
Winston-Salem, North Carolina, United States
View Trial DetailsNCT01310582
Calculi, Excessive Repair
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT00199459
Calculi, Female Urogenital Diseases
London, Ontario, Canada
View Trial Details